Diabetes & Endocrinology Perspective

 
 

  • Is It Possible to Predict the Risk for Pancreatic Cancer? A US-based team seeks to develop and validate a model allowing clinicians to predict the risk for pancreatic cancer.
  • Physician-Owned Hospitals: The Answer for Better Care?   Drs Robert Glatter and Brian Miller discuss the current and renewed interest in physician-owned hospitals.
  • Infographic: Can Doctors Meet Retirement Finances Goals? Physicians revealed how big of a retirement nest egg their families want. Doctors, on average, have met 77% of that goal already, so most of them are confident in funding their retirement.
  • Mandrola's Top 10 Cardiology Stories of 2023 Obesity drugs, factor XI inhibitors, and procedures such as TAVR, PCI, and TEER are among the top stories of 2023, according to cardiologist John Mandrola, MD.
  • Sodium Bicarbonate Use in the Emergency Department Two recent reviews may change how you use bicarb in the ED.
  • Spending the Holidays With GLP-1 RAs: 5 Things to Know Should patients on new antiobesity medications change their eating over the holidays? Beverly Tchang, MD, offers five tips that she shares with her patients.
  • Primary Care, Meet Lifestyle Medicine   Dr Kenny Lin speaks with Dr Alka Gupta about implementing lifestyle medicine into primary care practice, including billable shared medical appointments to help patients navigate lifestyle changes.
  • The Top Cardiology Trials of 2023   For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.
  • Cysteamine and Melasma Cysteamine is a natural agent that has recently garnered attention primarily for one indication: melasma.
  • Infographic: Female Physicians Close Their Wealth Gap Female physicians' survey answers about their net worth show a gender gap vs male doctors (although it's narrowing) and reveal their saving and borrowing habits.
  • How to Prescribe Zepbound Recently approved tirzepatide joins semaglutide as an option for patients with obesity. Beverly Tchang, MD, offers her recommendations based on her experience for prescribing.
  • Medscape Nurse Career Satisfaction Report 2023 Several categories of nurses describe what makes them happiest and unhappiest with their career, how the abuse they experience shapes their views, and other facets of career satisfaction.
  • Why Are Prion Diseases on the Rise?   Remember the outbreak of "mad cow disease" in the 1990s? Creutzfeldt-Jakob is increasing again, but this time, we don't know why.
  • Is Lifelong LDL-C Lowering Within Reach?   Michelle O'Donoghue interviews Verve CEO and cardiologist Sekar Kathiresan about PCSK9 gene editing to lower LDL cholesterol and the findings of the heart-1 study.
  • HDL-C Levels' Role in Cardioprotection: 5 Things to Know Targeting HDL-C function can be an effective strategy to understand mechanisms related to CV protection, which in turn can lead to the development of newer therapies to prevent CVD.
  • Change Makers: Bill Meury on Transformative Medicines Bill Meury, president and CEO of Karuna Therapeutics, speaks with WebMD Chief Medical Officer John Whyte, MD, about the differences in drug development in psychiatry and the importance of innovation.
  • Key Updates in Obesity From AHA 2023   Highlights in obesity from AHA 2023 include an overview of the SELECT and SURMOUNT trials, cost-effectiveness of weight loss therapies, and the association of obesity with the risk for heart failure.
  • Medscape Female Physician Wealth & Debt Report 2023 Female physicians discuss their track record in building family net worth and reveal how they feel about their savings, spending, investing, and other aspects of personal finance.
  • Dr Christmas on Managing Menopausal Symptoms   Dr Monica Christmas's gift to The Curbsiders is expert advice on using hormonal and nonhormonal therapies in perimenopause.
  • Semaglutide Reduces Cardio Risk in Obesity Without Diabetes   Anne Peters discusses recent data on semaglutide and cardiovascular outcomes in patients with preexisting cardiovascular disease and obesity, but with no history of diabetes.
  • EASD 2022
  • ECO 2022
  • DUKPC 2022
  • SfE BES 2021
  • DPC 2021
  • EASD 2021
  • DPC 2020
  • DUKPC 2021
  • EASD 2020